Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
ADAMAS PHARMACEU RG (NQ: ADMS)
27.27 USD  +0.03 (+0.11%)
Streaming Delayed Price  /  Updated: 3:00 PM EDT, Jul 19, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 124,357
Open 27.22
Bid (Size) 27.23 (200)
Ask (Size) 27.27 (200)
Prev. Close 27.24
Today's Range 26.90 - 27.50
52wk Range 13.50 - 44.00
Shares Outstanding 26,982,322
Dividend Yield N/A
Performance
YTD
-23.51%
-23.51%
1 Month
+5.70%
+5.70%
3 Month
+5.49%
+5.49%
6 Month
-25.57%
-25.57%
1 Year
+60.32%
+60.32%
Top News
More News
Adamas Announces New Employment Inducement Grant
Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today announced that the compensation committee of the company’s board of directors granted two new employees the option to purchase an aggregate of 29,531... Read More
from GlobeNewswire News Releases
Adamas Pharmaceuticals Earns Relative Strength Rating Upgrade; Hits Key Threshold
Adamas Pharmaceuticals shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 80 to 84. Read More
from Investor's Business Daily
More News
Read More
Stocks Generating Improved Relative Strength: Adamas Pharmaceuticals
from Investor's Business Daily
Adamas Presents New Data Analysis Demonstrating that GOCOVRI™ Reduces Transitions between Dyskinesia and OFF Episodes Throughout the Day
from GlobeNewswire News Releases
IBD Rating Upgrades: Adamas Pharmaceuticals Flashes Improved Relative Price Strength
from Investor's Business Daily
IBD Rating Upgrades: Adamas Pharmaceuticals Flashes Improved Price Strength
from Investor's Business Daily
Adamas Announces New Employment Inducement Grant
from GlobeNewswire News Releases
Adamas to Present at Two Upcoming Investor Conferences
from GlobeNewswire News Releases
Stock Upgrades: Adamas Pharmaceuticals Shows Rising Relative Strength
from Investor's Business Daily
Adamas Announces Publication of Pharmacokinetic Data for GOCOVRI™ in Clinical Pharmacokinetics
from GlobeNewswire News Releases
Adamas Announces New Employment Inducement Grant
from GlobeNewswire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.